comprehensive -WSS

comprehensive

author：entertainment 2025-08-28 08:40:57 - browse：5

Medicare and money photo illustration. — Adobe

WASHINGTON — A week after the Food and Drug Administration granted full, traditional approval to a new Alzheimer’s treatment, insurers are finalizing their plans to cover it as well as associated scans and diagnostic tests.

Medicare will cover most patients eligible for Leqembi, a new treatment developed by Eisai and Biogen to help slow the progression of Alzheimer’s disease. The drug, which has modest benefits, has potentially serious side effects for some patients including brain swelling and bleeding.

Medicare told STAT that it would cover brain scans and genetic testing that will help screen for and monitor potential side effects. Medicare already covers one amyloid PET scan per lifetime, but the agency is reconsidering that policy and plans to release a new proposed policy “soon,” an agency spokesperson said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Nobel honors Karikó and Weissman's enduring partnership

entertainment

WSS

How to address the problem of discarded donor organs

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Medical device lobby: We're tired of waiting on Medicare coverage

Health insurers' Q3 question: how much care are people getting?

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Experts study whether long Covid risk adds up with each reinfection

focus

comprehensive

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

Setback for rare diseases as Taysha Gene Therapies pulls back

Dobbs anniversary: the lost opportunity of abortion as health care

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

Drug repurposing or repositioning? The language matters

With Roe v Wade overturned, abortion providers work to adapt

Sports medicine is finally prioritizing gender equality

Medicare innovation center doesn’t save money, experts say

Bright Health sells Medicare Advantage business to Molina

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

knowledge

The stability of $0 premiums in Medicare Advantage

CRISPR base editing slashes cholesterol levels in monkeys

House looks to weaken Medicare negotiation

Will an HIV vaccine ever be a reality?

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

With Roe v Wade overturned, abortion providers work to adapt

focus

entertainment

entertainment

focus